Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
Hematology
Research output
:
Contribution to journal
›
Review article
›
peer-review
400
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Comb and Wattles
100%
Janus Kinase 2
97%
Isocitrate Dehydrogenase
94%
Zinc Fingers
78%
Leukemia
56%
Viruses
46%
Mutation
38%
Neoplasms
22%
Juvenile Myelomonocytic Leukemia
15%
Myelopoiesis
14%
Mastocytosis
13%
Clonal Evolution
13%
Blast Crisis
13%
Essential Thrombocythemia
13%
Janus Kinases
13%
Polycythemia Vera
12%
Primary Myelofibrosis
12%
Proto-Oncogenes
11%
Myelodysplastic Syndromes
11%
Oncogene Proteins
11%
Transducers
10%
Hematopoietic Stem Cells
9%
Acute Myeloid Leukemia
9%
Oncogenes
9%
Epigenomics
8%
Lymphoma
8%
Clone Cells
7%
Phenotype
5%
Incidence
4%